Shares of BioRem Inc. (CVE:BRM – Get Free Report) were up 16% on Wednesday. The company traded as high as C$4.41 and last traded at C$4.35. Approximately 100,846 shares were traded during mid-day trading, an increase of 339% from the average daily volume of 22,966 shares. The stock had previously closed at C$3.75.
BioRem Stock Performance
The stock has a market capitalization of C$70.82 million, a PE ratio of 13.01 and a beta of 0.77. The company has a debt-to-equity ratio of 14.17, a quick ratio of 1.08 and a current ratio of 2.04. The firm’s 50 day moving average is C$3.58 and its two-hundred day moving average is C$3.11.
Insider Activity
In related news, Director Derek Webb sold 28,700 shares of BioRem stock in a transaction on Monday, August 24th. The stock was sold at an average price of C$3.82, for a total value of C$109,634.00. Following the completion of the transaction, the director directly owned 362,370 shares in the company, valued at approximately C$1,384,253.40. This trade represents a 7.34% decrease in their ownership of the stock. Insiders own 1.90% of the company’s stock.
BioRem Company Profile
BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems.
Further Reading
- Five stocks we like better than BioRem
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.
